Pink Sheet Podcast: New Drug Submissions Lag, FDA EUAs On The Way, BsUFA Revenue Misses Estimates

Citeline Podcasts - A podcast by Citeline

Try Bookbeat 60! days for free, click here

Try Bookbeat 60! days for free, click here

Enjoy a whole world of audiobooks and e-books, everything from new releases to the classics

 Sponsored

Categories:

Business

Pink Sheet reporter and editors discuss the lower new drug submission rate in 2020, another EUA for a potential coronavirus treatment, and the biosimilar user fee program missing revenue estimates again.

Visit the podcast's native language site